ZNF37CP

Across TCGA pan-cancer cohorts, ZNF37CP RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of ZNF37CP’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where ZNF37CP RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF37CP is over-expressed in tumor, although a few such as THCA and BRCA show the opposite, repressed pattern.

KIRC, HNSC, and KIRP are the cancer types where ZNF37CP tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF37CP RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+2.466	<.001	12	view →
HNSC	All	All	+0.231	.003	9	view →
KIRP	Male	II,III,IV	+2.047	<.001	8	view →
THCA	Female	All	−0.848	<.001	7	view →
BRCA	Female	II,III,IV	−0.361	<.001	6	view →
READ	All	All	−0.441	<.001	5	view →
KICH	Female	All	−0.494	.004	3	view →
UCEC	All	IV	−0.860	.041	2	view →
BLCA	Male	III,IV	−0.481	.019	2	view →
PRAD	All	All	−0.270	.001	2	view →
LIHC	Male	All	+0.248	.009	2	view →
COAD	Male	IV	+0.390	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

ZNF37CP–KIRC

Open the KIRC breakdown →